top of page

Acquiring a MIS Market Position​

Rumor has it Enovis is acquiring Novastep from Amplitude Surgical SAS, a public company listed on the Paris stock exchange. The gold nuggets for Enovis in the Novastep portfolio are the MIS portfolio and Fusionframe external fixation.

Novastep MIS portfolio?

MIS is a rapidly growing sector of the foot and ankle space and Novastep has a solid position. First launched in 2019, PECA implant systems for MIS bunion cuts and fixation underwent updates in 2021 with the launch of a guided instrumentation and implant platform PecaPlasty for percutaneous bunion correction.

Enovis is a player

With sales of $1.4 billion and growing at a robust 27.3%, annually, Enovis is ranked 6th among the largest orthopedic companies. Watch for its continued push in the foot and ankle space.

9 views0 comments

Recent Posts

See All

BioAventis has agreed to sell its wound business to LifeNet Health, which includes skin substitutes TheraSkin and TheraGenesis. The transaction includes a total cash consideration of $85 million. Indu

Dr. Ned Amendola MD, FAAOS, FRCS(C) from Duke University was named second vice president of the American Academy of Orthopedic Surgeons (AAOS) and will ascend to president in 2025-2026. Fellowship tra

As speculated in February 2023 FIX, Enovis announced early this week that it has consummated a deal for Novastep with the MIS bunion system being the prize along with access to a robust OUS sales chan

FIX Masthead 2000x318 v2.jpg
bottom of page